oncology
SGX Pharmaceuticals, Inc. (SGXP) Submits FDA Investigational New Drug Application
Read the full article: http://blog.qualitystocks.net/?p=11110
SGX Pharmaceuticals is a biopharmaceutical company which focuses mainly on the development and commercialization of new oncological, or cancer therapies. Yesterday, the company announced its submission of an Investigational New Drug (IND) application for FDA approval.
- Login or register to post comments
- Email this page
Molecular Insight Pharmaceuticals, Inc. (MIPI) CEO Presents at Healthcare Conference
Read the full article: http://blog.qualitystocks.net/?p=10863
During the Jefferies 2nd Annual Healthcare Conference in New York, David S. Barlow, the chairman and CEO of Molecular Insight Pharmaceuticals, Inc. (MIPI) presented on the fast growing field of molecular medicine.
- Login or register to post comments
- Read more
- Email this page
Related Articles
- Molecular Insight Pharmaceuticals, Inc. (MIPI) CEO Presents at Healthcare Conference
- SGX Pharmaceuticals, Inc. (SGXP) Submits FDA Investigational New Drug Application
- Oxygen Biotherapeutics Inc. (OXBO.OB) to Submit Test Protocol to FDA for Multi-Center Study for Traumatic Brain Injury
- GenVec, Inc.’s (GNVC) TNFerade™ Gets FDA Fast Track Designation for Pancreatic Cancer Treatment
- Del Global Technologies Corp. (DGTC.OB) Completes Another Successful Imaging Installation